Abstract-Contamination of surface waters by pharmaceutical chemicals has raised concern among environmental scientists because of the potential for negative effects on aquatic organisms. Of particular importance are pharmaceutical compounds that affect the nervous or endocrine systems because effects on aquatic organisms are possible at low environmental concentrations. Selective serotonin reuptake inhibitors (SSRIs) are drugs used to treat clinical depression in humans, and have been detected in low concentrations in surface waters. In this investigation, the acute and chronic toxicity of five SSRIs (fluoxetine, Prozac; fluvoxamine, Luvox; paroxetine, Paxil; citalopram, Celexa; and sertraline, Zoloft) were evaluated in the daphnid Ceriodaphnia dubia. For each SSRI, the 48-h median lethal concentration (LC50) was determined in three static tests with neonate C. dubia, and chronic (8-d) tests were conducted to determine no-observable-effect concentrations (NOEC) and lowest-observable-effect concentrations (LOEC) for reproduction endpoints. The 48-h LC50 for the SSRIs ranged from 0.12 to 3.90 mg/L and the order of toxicity of the compounds was (lowest to highest): Citalopram, fluvoxamine, paroxetine, fluoxetine, sertraline. Mortality data for the 8-d chronic tests were similar to the 48-h acute data. The SSRIs negatively affected C. dubia reproduction by reducing the number of neonates per female, and for some SSRIs, by reducing the number of broods per female. For sertraline, the most toxic SSRI, the LOEC for the number of neonates per female was 0.045 mg/L and the NOEC was 0.009 mg/L. Results indicate that SSRIs can impact survival and reproduction of C. dubia; however, only at concentrations that are considerably higher than those expected in the environment.
INTRODUCTION
The presence of pharmaceutical chemicals in aquatic environments was first recognized in the mid-1970s [1] . Recently, review articles describing the potential for these contaminants to negatively affect aquatic organisms have generated interest in conducting research on this topic [2, 3] . Contamination of aquatic environments by pharmaceutical chemicals can result from surface water runoff, groundwater seepage, untreated wastewater, and also after passage of wastewaters through sewage treatment plants not designed to remove these substances. For most of these chemicals, the environmental fate and ecotoxicological characteristics are unknown [3] . Of particular ecotoxicological concern are drugs that affect nervous and endocrine systems because disruption of physiological processes in aquatic organisms can occur at low environmental concentrations.
Selective serotonin reuptake inhibitors (SSRIs) are a group of drugs prescribed in human medicine to treat clinical depression and some compulsive disorders. These compounds block serotonin reuptake sites on cell membranes and lead to elevated levels of serotonin (5 hydroxytryptamine ), a neurotransmitter, and increase transmission by serotonergic neurons. Currently in the United States, SSRIs (e.g., fluoxetine, Prozac; Eli Lilly and Company, Indianapolis, IN, USA) are in the top 200 of most-prescribed drugs (http:www.rxlist.com/ top200.htm) and patients typically continue treatment over long periods of time. Given these factors, large metropolitan areas in industrialized countries likely have measurable quan-tities of SSRIs and their metabolites continuously arriving at sewage treatment plants. While information on the efficacy of sewage treatment plants at removing SSRIs and their metabolites from effluents is lacking, recent studies have reported the SSRI fluoxetine at parts per trillion levels in surface waters receiving treated wastewater [4, 5] . The potential exists for other SSRIs to be present in wastewater and for contamination of aquatic environments to occur. Although SSRIs and their metabolites only occur in low concentrations (ng/L) in the environment, negative effects on aquatic organisms are possible.
The effects of specific SSRIs have been investigated in both vertebrates and invertebrates, but little research has been done in the context of environmental contamination. Because 5-HT is an important compound for some biological functions in aquatic organisms, including fish [6, 7] , crustaceans [8] [9] [10] , and molluscs [11] [12] [13] , the potential exposure of aquatic organisms to SSRIs in the environment is important. Some SSRIs have been used in experiments to elucidate the physiological importance of 5-HT in aquatic organisms and have been linked to gonadal maturation [8] , induction of parturition [14] , metamorphosis [12] , and spawning [13] in aquatic invertebrates. Aqueous concentrations of the SSRI fluvoxamine (Luvox, Solvay Pharmaceuticals, Weesp, The Netherlands) as low as 10 Ϫ10 M (32 ng/L) have been found to induce spawning in male zebra mussels Dreissena polymorpha [14] .
The toxicity of SSRIs to aquatic organisms is not well documented in the peer-reviewed literature. Brooks et al. [15] investigated the toxicity of fluoxetine to aquatic vertebrates and invertebrates in standardized tests and reported no-observable-effect concentrations (NOEC) of 56 g/L for repro-duction in Ceriodaphnia dubia. Results of several unpublished acute toxicity tests indicate toxicity of fluoxetine HCl and paroxetine HCl (Paxil, Glaxo Smith Kline, Research Triangle Park, NC, USA) and report 0.9 to 3.0 mg/L as the concentration affecting (mortality and unspecified effects) 50% of test organisms [16] .
A starting point in evaluating the importance of SSRIs as environmental contaminants is to conduct standardized aquatic toxicity tests to determine the toxicity of these compounds and to determine if toxic effects can be expected at environmentally relevant concentrations. The objectives of the present study were to evaluate the acute and chronic toxicity of five SSRIs: Fluoxetine, sertraline (Zoloft, Pfizer, New York, NY, USA), fluvoxamine, citalopram (Celexa, Forest Laboratories, New York, NY, USA), and paroxetine to C. dubia. Ceriodaphnia dubia is a daphnid (class Crustacea) used in standardized tests to evaluate the toxicity of contaminants in aquatic environments [17, 18] .
MATERIALS AND METHODS

Culturing of test organisms
Ceriodaphnia dubia were obtained from the U.S. Environmental Protection Agency (U.S. EPA Region IV Ecological Services Laboratory, Athens, GA) and stock cultures were maintained for several months prior to initiation of tests. [17] . Daily records of C. dubia reproduction were kept for all stock cultures and only neonates from third or fourth broods containing eight or more neonates were used for toxicity tests.
SSRI purification and analysis
The SSRIs used in tests were extracted from formulations (tablets obtained from pharmacies by prescription) with appropriate solvents by sonication and purified by recrystallization. After purification and recrystallization, all SSRIs were injected onto a high-performance liquid chromatography (HPLC) and the chromatographic response was monitored at 210 nm to determine purity. The purities of recrystallized products were 99.78%, fluoxetine; 99.54%, sertraline; 99.86%, paroxetine; 99.88%, fluvoxamine; and 99.50%, citalopram. Mass spectra of recrystallized fluoxetine and fluvoxamine also were evaluated and showed the same patterns as authentic standards (Sigma-Aldrich). For the other SSRIs authentic standards were not available, however, mass spectra of recrystallized products showed the same patterns as published spectral data.
A 100-mg/L stock solution was prepared by adding the salt form of the SSRI (HCl salts for all SSRIs except citalopram HBr and fluvoxamine maleate) to ultrapure water (Milli Q) [17] . Each solution was sonicated for 2 h prior to use to facilitate complete dissolution of crystals. 
Toxicity bioassays
Methods for acute and chronic toxicity tests with C. dubia conformed to guidelines defined by the U.S. EPA [17, 18] . For acute toxicity tests, five neonate C. dubia within 8 h of the same age and all less than 24-h-old were pipetted into 30-ml plastic cups, each containing 15 ml of MHW (control) or the test chemical dissolved in MHW. Ceriodaphnia dubia were not fed during acute toxicity tests. For each experiment with an SSRI, five treatment concentrations were tested, 20 neonates (4 cups) were exposed to each treatment concentration and the control, and mortality was assessed after 48 h. Three acute toxicity tests were conducted for each SSRI, and the three tests were conducted with broods from two or three different generations of the stock culture. After 48-h tests, the DO and pH were measured (as described above) and acceptable levels (DO, 5.6-6.8 mg/L; pH, 8.1-8.35) were found in each of the test cups [17] .
Chronic tests were initiated with C. dubia less than 24-hold and within 8 h of the same age, and continued until at least 60% of controls (not exposed to an SSRI) had three broods of offspring (7 Ϯ 1 d). Five treatment concentrations (prepared as described above) were tested for each SSRI, and each treatment and the control had ten replicates. Each replicate consisted of a randomly selected neonate in a 30-ml plastic cup containing 15 ml of test water. At approximately the same time each day, C. dubia were transferred to new cups containing freshly made test solutions and food (as above). At the same time the C. dubia were transferred to new cups, survival and reproduction data were recorded [18] .
Quality assurance and quality control measures were employed in both acute and chronic tests. For acute test acceptance, survival of control organisms must exceed 90%. In addition, in corresponding tests with the reference toxicant CuSO 4 (in MHW), the LC50 must not deviate by more than two standard deviations from the mean values computed for our laboratory. The 48-h LC50 for reference toxicity tests that corresponded to the acute toxicity tests for each of the SSRIs ranged from 9.33 to 12.31 g Cu 2ϩ /L and all were within acceptable limits for our laboratory. Chronic tests were acceptable if survival of the control organisms was at least 80% and if at least 60% of the surviving control adults produced three broods of offspring in 7 Ϯ 1 d [18] .
Statistics
The 48-h LC50 for each SSRI in acute toxicity tests was computed by the Trimmed Spearman-Karber method (Trimmed Spearman-Karber Method Ver 1.5) [17] with the concentrations adjusted based on the mean of the initial and 48-h concentrations of analyzed samples. In the chronic experiments, the number of neonates/female, time-to-first-brood, and number of broods/female were evaluated by analysis of variance, and Levene's test was conducted to determine if the homogeneity of variance assumption was violated. Dunnett's test was then used to detect differences between the control and each treatment level to distinguish the NOEC and lowestobservable-effects concentrations (LOEC) at a significance level of 0.05. When the homogeneity of variance assumption was not met, the Wilcoxon Rank Sum test was used to detect differences (p Յ 0.05) between the control and treatment levels. All statistical analyses for chronic tests were conducted with Statistical Analysis Software (Ver 8.0, SAS Institute, Cary, NC, USA).
RESULTS AND DISCUSSION
Analysis of water samples collected at the initiation of acute toxicity tests indicated that nominal concentrations of each SSRI differed by 1 to 12% from measured concentrations (Table 1). After 48 h in the 30-ml plastic cups used as exposure chambers, measured concentrations of each SSRI varied by 4 to 10% from nominal concentrations for sertraline, fluoxetine, paroxetine, and citalopram. Fluvoxamine was an exception, and the concentration decreased by 60% during the 48-h test. When SSRI concentrations were analyzed after 48 h in the presence of C. dubia, measured concentrations differed by 1 to 7% relative to nominal concentrations for all SSRIs except fluvoxamine, which was 76% lower than the nominal concentration.
Lower concentrations of fluvoxamine after the 48-h test indicate that this compound was being lost from solution. Unfortunately, no published information exists on the stability of fluvoxamine in aqueous environments. Preliminary results indicate that fluvoxamine has a water solubility of 14.8 mg/ml and appears relatively stable to hydrolysis in pH 5, 7, and 9 buffer solutions for 30 d at 25ЊC; however, the compound was degraded moderately by photolysis. Rates of photolysis in the first stage (0-7 d) were much higher than in the second stage (7-30 d) with half-lives of 5.62, 6.00, and 3.62 d in the first stage, and 16.23, 14.11, and 16.54 d in the second stage in pH 5, 7, and 9 buffer, respectively (Armbrust and Kwon, Mississippi State Chemical Laboratory, Mississippi State, MS, USA, unpublished data). These results indicate that photolysis could explain the loss of fluvoxamine during the 48-h acute toxicity tests, as tests were conducted under a 16:8-h light: dark photo period. If fluvoxamine is susceptible to photolysis in aquatic environments, the importance of this SSRI as an environmental contaminant is reduced because it may not persist long enough to induce negative biological effects.
Mortality of C. dubia increased with increasing concentration of each SSRI and the 48-h LC50 values ranged from 0.12 mg/L for sertraline to 3.90 mg/L for citalopram ( Table 2 ). The only other published results on the toxicity of SSRIs to C. dubia indicate a 48-h LC50 of 0.234 mg/L fluoxetine HCl [15] , which is comparable to the 48-h LC50 (0.51 mg/L) found in the present study. Brooks et al. [15] also report 0.820 mg/ L fluoxetine HCl as the 48-h LC50 for another cladoceran, Daphnia magna. We observed that the locomotion of C. dubia was reduced at SSRI concentrations below the LC50 for all compounds; however, these effects were not quantified. Serotonin is an important neurotransmitter in crayfish Astacus astacus affecting locomotion and the decision to retreat when confronted with an aggressor conspecific [19] , and also could be involved in regulation of behavior in other crustaceans including C. dubia. The potential for SSRIs present in aquatic environments to affect endogenous serotonin concentrations and affect behavior of crustaceans has not been evaluated.
Chronic exposure to each of the SSRIs reduced the mean number of neonates produced by C. dubia during the 7-to 8-d tests (Table 3 ). The SSRI with the lowest concentration to affect the mean number of neonates produced (LOEC) was sertraline (0.045 mg/L) and the highest LOEC was measured upon exposure to citalopram (4 mg/L). For fluoxetine, the NOEC for the mean number of neonates was 0.089 mg/L, which was similar to the NOEC (0.056 mg/L fluoxetine HCl) reported by Brooks et al. [15] , using the same standardized 7-d chronic toxicity test with C. dubia. The chronic toxicity of other SSRIs have not been published previously for C. dubia. The time-to-first-brood was not significantly affected after exposure to any of the SSRIs at the concentrations tested; however, the number of broods produced in 7 d was reduced after exposure to fluvoxamine, fluoxetine, and paroxetine but not by the other SSRIs at the concentrations tested.
Although the objective of the present study was to evaluate acute and chronic toxicity of SSRIs, other studies have eval- uated the potential for SSRIs to stimulate reproduction and improve culture techniques of aquatic organisms. Induction of spawning in male zebra mussels has been observed at aqueous fluvoxamine concentrations as low as 10 Ϫ10 M (0.032 g/L) [14] , which is considerably lower than the NOEC (0.366 mg/ L, fluovoxamine) observed for inhibition of reproduction of C. dubia in the present study. Fong [14] found that the concentrations necessary to induce spawning in zebra mussels varied considerably among different SSRIs and the rank order of the potencies of the three SSRIs tested differed from the results of the present study. The rank order of toxicity of the SSRIs in the present study was (lowest to highest) citalopram, fluvoxamine, paroxetine, fluoxetine, and sertraline, while Fong et al. [13] found that fluvoxamine was more potent than fluoxetine at inducing spawning and paroxetine was the least effective. The difference in relative rank order potency for SSRIs in these studies could be because of interspecies differences or because the SSRIs are acting through different mechanisms. Although Fong et al. [13] found that SSRIs were potent spawning inducers, they were not able to conclude whether the SSRIs were inhibiting reuptake of serotonin or acting through some other mechanism. The present study evaluated SSRI concentrations that negatively affected C. dubia reproduction; however, lower SSRI concentrations that were not tested could disrupt reproduction by decreasing the timeto-first-brood or increasing the number of broods and neonates per female.
The environmental relevance of laboratory acute and chronic toxicity data is important to consider when interpreting the potential for SSRIs to negatively affect aquatic ecosystems.
Fluoxetine has been detected in aquatic environments at estimated concentrations of 99 ng/L [5] in effluent-dominated streams, which is considerably lower than the LC50s and LOECs determined for any of the SSRIs examined in the present study. Though these results suggest that the presence of SSRIs in the environment at previously detected concentrations may not negatively affect aquatic organisms, actual environmental conditions are different because organisms are exposed to a diverse mixture of contaminants (including SSRIs) and exposure occurs over multiple generations [3] . Future research should investigate the effects of mixtures of SSRIs on aquatic organisms and the effects of exposure over multiple generations.
